Abstract
The global emergence of antibacterial resistance poses a severe threat to human life, echoing Alexander Fleming's cautionary prediction about the misuse of antibiotics. In the current era, many existing antibacterials are increasingly losing effectiveness against various microorganisms. Overuse and suboptimal exposure provide fertile ground for microbial thriving and the development of resistance through mechanisms like cell membrane protection, target modification, enzymatic inactivation, and drug efflux. Conventional drug delivery systems struggle against this evolving bacterial resistance. Consequently, there's a pressing need for innovative strategies to combat antibacterial drug resistance. Nanotechnology-based targeted drug delivery systems offer a promising solution. These systems enhance drug solubility, permeability, bioavailability, stability, and efficacy while minimizing toxicity. This chapter explores the concept of targeted drug delivery to address antibacterial resistance, focusing on mechanisms, approaches, and recent advancements.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
